Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Arkray's Glucocard Vital gets FDA OK

This article was originally published in Clinica

Executive Summary

The US FDA has granted 510(k) clearance for Arkray's Glucocard Vital blood glucose monitoring system. The Japanese diagnostics firm will start distributing the device in early December. The meter and strip platform will be "ideal" for the home medical equipment, durable medical equipment, mail order and managed care markets, Arkray believes. The new addition to the Glucocard brand requires only 0.5 microlitres of blood and holds 250 downloadable tests in its memory.

Advertisement

Topics

UsernamePublicRestriction

Register